Stock Market - It's not just chip stocks. More than 500 stocks with a market cap of $700M or more are down more than 12% in the last four weeks.

---

• It's not just chip stocks. More than 500 stocks with a market cap of $700M or more are down more than 12% in the last four weeks.
• Amazon refocuses interest in Manhattan office space after dropping Long Island City deal
• Stocks – in the eye of the storm
• Qualcomm asks US judge to put anti-trust ruling on hold while chipmaker appeals
• The 20 point recession checklist.
• Intraday scanning by relative volume ?
• Tried to help you get out the market months ago
• ELI5: Finla Prospectus - Rights offering. Link inside
• $PSIQ $1.00+ Coming - UPDATE -- PSIQ to Receive Assignment of License to Prepare Land in Israel With the Intent to Grow, Cultivate, Distribute and Export Medical Cannabis. Massive increase in revenues.
• Hypothetical question
• Be Warned, McDonald’s Investors: The Fast Food Giant is Slow to Adapt
• $INNV Following Its Recent Approval from Health Canada for the Relief of Neuropathy Pain, Innovus Pharma Announces Receipt of Notification to Commercialize Diabasens® in the European Union

It's not just chip stocks. More than 500 stocks with a market cap of $700M or more are down more than 12% in the last four weeks. Posted: 28 May 2019 03:07 PM PDT Thank you China trade war. submitted by /u/Dems4Prez [link] [comments]

Amazon refocuses interest in Manhattan office space after dropping Long Island City deal Posted: 28 May 2019 05:07 AM PDT https://www.marketwatch.com/story/amazon-refocuses-interest-in-manhattan-office-space-after-dropping-long-island-city-deal-2019-05-28 Amazon may have bid farewell to Queens, but it still "hearts" the Big Apple. After walking away from a deal to build a headquarters on the Queens waterfront in Long Island City, Amazon is back to shopping for office space on Manhattan's West Side, sources tell The Post. submitted by /u/coolcomfort123 [link] [comments]

Stocks – in the eye of the storm Posted: 28 May 2019 07:00 PM PDT [Original post] It's hard to reconcile stability in US stock markets given gathering sings of a storm. The S&P 500 is still up 13% on the year, NDX 15.8% and China A-shares 16.7%. At the same time the Fed-funds futures are pricing in almost a certainty of a Fed rate cut by December, and a good chance of more. This tranquility comes amid material changes in global political landscape. One can dismiss the EU parliamentary elections last week as a protest vote with the results "less bad" than expected. But the losses of centrist statist parties to the fringes, be it on the right or left, are impressive. The British two-party system took a mortal blow with Conservatives taking 9% of the vote and Labor 14%. The political continuity in Germany looks shaky, Macron's party lost to Le Pen, and Italy looks set to get a Lega government this year. The impact of the elections will entrench the sense of unease, prolong the Brexit uncertainty and remove any possibility if European economy pulling its weight anytime soon. There is no longer a path to roll-back the US-China trade war. China hasn't retaliated sparing US tech firms. But the lack of retaliation is not a sign of giving in, just a cold cost-benefit analysis as retaliation hurts US less. China announced measures to decouple from western supplies in telecoms infrastructure. The besieged Huawei is rolling out a replacement for Android operating system. The narrative from mainland news media and pundits is that the US consumers will pay the lion share of the tariffs and the loss of market share in the US is acceptable. President Xi is preparing the public for prolonged tensions and hardship. In the absence of Chinese concessions, tariffs will go higher again at the end of June damping business sentiment across the globe. There is also an issue of the US elections in 2020. Prediction markets and most forecasts favor a democratic president and house. Trump could potentially squeeze through, but only if the economy is doing well. That creates a negative feedback loop for the market – the worse the economy does the more ominous the election looms. What does it mean for the stock market? The most logical explanation is it will expect the Fed to ease quickly as US economic data sag. The QE playbook will be dusted out as well if rates would need to go to the zero bound. After all ECB hasn't been able to lift rates once since Greece, and the German 10y yields are once again negative. Japan has resigned to zero interest rates for 10y bonds for the foreseeable future. The experience of the last 10 years was that the stock market in the US keeps moving up without large drawdowns helped by policy support when needed. However, it seems implausible that all such stimulus will happen while the stock market is only muddling through. We are in the eye of the storm, and it can only get worse before it gets better. submitted by /u/varturas [link] [comments]

Qualcomm asks US judge to put anti-trust ruling on hold while chipmaker appeals Posted: 28 May 2019 06:58 PM PDT https://www.cnbc.com/2019/05/29/qualcomm-asks-us-judge-to-put-anti-trust-ruling-on-hold-amid-appeals.html Qualcomm said that it believes it can succeed in appealing the May 21 decision by U.S. District Judge Lucy Koh in an antitrust case brought by the U.S. Federal Trade Commission in January 2017. The company has not yet filed that appeal; Tuesday's filing only concerns whether the ruling's provisions will be put on hold temporarily as it plays out. submitted by /u/coolcomfort123 [link] [comments]

The 20 point recession checklist. Posted: 28 May 2019 06:55 PM PDT The list below shows the typical playbook for markets and the economy when the Fed hikes rates. This list aims to simplify the cycle. Recession checklist Number: 4 Housing sentiment weakened last year, but it's starting to rebound this year. New home sales hit a new record high in March which was the first cycle high since November 2017. The more interest rates fall, the stronger the housing market will get (all else being equal). The housing market's recession signal might be reversed. Number: 7 While earnings revisions have been weak in May, there was an earnings recession from 2014-2016 which didn't lead to an economic recession. Number: 16 The May Markit flash PMI reading came close to falling below 50 as it was 50.9. It has only barely and briefly fallen below 50 a couple times this cycle. Number: 12 Technically, the University of Michigan preliminary consumer confidence index reached a 15 year high in May. It was helped by the 15 year high in the expectations index. 20 Steps To A Recession submitted by /u/AlexPitti [link] [comments]

Intraday scanning by relative volume ? Posted: 28 May 2019 06:50 PM PDT Is it possible to scan for stocks based on intraday relative volume ? For example, I would like to know if a stock is trading at X times the normal volume . Thank you for any help ! submitted by /u/theforrr [link] [comments]

Tried to help you get out the market months ago Posted: 28 May 2019 06:31 PM PDT Big money pumped up all these garbage stocks to start the year. I tried to get you and your retail money out before the downturn. https://www.reddit.com/r/StockMarket/comments/aydpbu/first_hand_evidence_of_a_coming_recession/?utm_source=share&utm_medium=ios_app&utm_name=ios_share_flow_optimization&utm_term=control_2 submitted by /u/Boomroomguy [link] [comments]

ELI5: Finla Prospectus - Rights offering. Link inside Posted: 28 May 2019 06:02 PM PDT https://polymetmining.com/investors/news/polymet-announces-filing-of-final-prospectus-and-terms-for-rights-offering/ ​ From the article: ​ " For each common share you hold on the Record Date you will receive one Right. For every Right, you will be able to subscribe for 2.119069 new common shares (subject to applicable law) at US$0.3881. For example, if you own 1,000 shares, you will receive 1,000 rights which allow you to subscribe for 2,119 new common shares for a total cost of US$822.38. " ​ It goes on to say that if I do not do this, I risk massively diluting my shares. Is this like a more-or-less mandatory double down? submitted by /u/BoomShackles [link] [comments]

$PSIQ $1.00+ Coming - UPDATE -- PSIQ to Receive Assignment of License to Prepare Land in Israel With the Intent to Grow, Cultivate, Distribute and Export Medical Cannabis. Massive increase in revenues. Posted: 28 May 2019 09:11 AM PDT Their PR department replied to a trader in Discord WTL room, saying they will be officially announcing the closing of their biggest deal to date. Hinted at following, ​ UPDATE -- PSIQ to Receive Assignment of License to Prepare Land in Israel With the Intent to Grow, Cultivate, Distribute and Export Medical Cannabis to the Projected $57 Billion Global Legal Cannabis MarketPress Release | submitted by /u/jarred_tok [link] [comments]

Hypothetical question Posted: 28 May 2019 12:23 PM PDT If the market were to tank and stocks go down in value will index fund be affected as well Say VTTSX (Vang. 2060 Retirement) and VTSAX currently @ $34.5/ VTSAX @$70.35 will they go down for example to like $25/55 ? Thanks submitted by /u/bszb [link] [comments]

Be Warned, McDonald’s Investors: The Fast Food Giant is Slow to Adapt Posted: 28 May 2019 10:55 AM PDT https://sentientmedia.org/be-warned-mcdonalds-investors-the-fast-food-giant-is-slow-to-adapt/ Summary: unlike many competitors, MCD hasn't announced plans or taken concrete steps to add plant-based options on their menus, despite surging interest in replacing meat by less destructive options, especially by the younger demographics. Thursday's shareholder meeting didn't promise any improvements. submitted by /u/mikkoj [link] [comments]

$INNV Following Its Recent Approval from Health Canada for the Relief of Neuropathy Pain, Innovus Pharma Announces Receipt of Notification to Commercialize Diabasens® in the European Union Posted: 28 May 2019 09:22 AM PDT https://www.otcmarkets.com/stock/INNV/news/Following-Its-Recent-Approval-from-Health-Canada-for-the-Relief-of-Neuropathy-Pain-Innovus-Pharma-Announces-Receipt-of-N?id=229545 Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men's and women's health and respiratory diseases, today announced that it has received the CPNP notification number required to commercialize Diabasens® in all 28 member countries of the European Union. This represents the fourth Innovus Pharma product to receive CPNP notification in the European Union in the last few years, the others being for Zestra®, Zestra Glide® and Sensum+®. The product will be available as an over-the-counter ("OTC") or behind the counter product and does not require a prescription. "We are pleased to announce the receipt of the CPNP in the European Union for Diabasens®, our current best-selling product. The clearance to market the product in Europe follows the recently announced approval from Health Canada for the relief of neuropathy pain," said Dr. Bassam Damaj, President and Chief Executive Officer of Innovus Pharma. "This is one of several products we have filed in Europe which we expect to receive the notification to commercialize in the near future." The product will be launched initially in France, the United Kingdom, Italy, Germany and Spain through our Pan-European Amazon® store, followed by local distributors in the second half of 2019. In addition to the US, Canada and the European Union, Innovus Pharma is working with certain regulatory agencies in Japan and throughout certain countries in Latin America to obtain appropriate marketing authorizations to eventually launch the product in that country and region. About Diabasens® Diabasens® is a Natural Health Product approved by Health Canada for the relief of neuropathy pain. It is a proprietary formulation to increase local sensation and blood flow. The product is also commercialized in the U.S. under the cosmetic classification. submitted by /u/louied91 [link] [comments]

You are subscribed to email updates from r/StockMarket - Reddit's front page of the stock market, financial news. To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google, 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States